Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0063 | 0.302 | 0.2982 |
Loa Loa (eye worm) | TAR-binding protein | 0.0063 | 0.3029 | 0.2991 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0043 | 0.1969 | 1 |
Brugia malayi | CXXC zinc finger family protein | 0.0029 | 0.126 | 0.1213 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0244 | 0.0216 |
Schistosoma mansoni | cpg binding protein | 0.003 | 0.1344 | 0.1523 |
Schistosoma mansoni | hypothetical protein | 0.0063 | 0.302 | 0.3421 |
Plasmodium vivax | histone acetyltransferase GCN5, putative | 0.0043 | 0.1969 | 0.8272 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0007 | 0.0155 | 0.0175 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0145 | 0.7202 | 0.8148 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.3029 | 0.3431 |
Schistosoma mansoni | hypothetical protein | 0.0177 | 0.8828 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0063 | 0.302 | 0.2982 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0007 | 0.0155 | 0.0114 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.3029 | 0.3431 |
Schistosoma mansoni | zinc finger protein | 0.0005 | 0.0054 | 0.0062 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0145 | 0.7202 | 0.8159 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.3029 | 0.3431 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0043 | 0.1969 | 0.2182 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0051 | 0.238 | 0.5 |
Echinococcus granulosus | cpg binding protein | 0.003 | 0.1344 | 0.147 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0029 | 0.126 | 0.1213 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0094 | 0.4578 | 0.5156 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.3029 | 0.3431 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0063 | 0.302 | 0.338 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0051 | 0.238 | 0.5205 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0007 | 0.0155 | 0.0114 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0063 | 0.302 | 0.2982 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0063 | 0.302 | 0.2982 |
Echinococcus multilocularis | GPCR, family 2 | 0.0063 | 0.302 | 0.338 |
Onchocerca volvulus | 0.0029 | 0.126 | 0.5 | |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0094 | 0.4578 | 0.5156 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0058 | 0.2758 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0051 | 0.238 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0063 | 0.3029 | 0.2991 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.02 | 1 | 1 |
Loa Loa (eye worm) | histone methyltransferase | 0.0009 | 0.0244 | 0.0191 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0094 | 0.4578 | 0.5156 |
Schistosoma mansoni | hypothetical protein | 0.0177 | 0.8828 | 1 |
Schistosoma mansoni | cpg binding protein | 0.0029 | 0.126 | 0.1428 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0063 | 0.302 | 0.338 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.0145 | 0.7202 | 0.7187 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0094 | 0.4578 | 0.5186 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.238 | 0.2338 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0063 | 0.302 | 0.338 |
Schistosoma mansoni | hypothetical protein | 0.0063 | 0.302 | 0.3421 |
Echinococcus multilocularis | mixed lineage leukemia protein mll | 0.0007 | 0.0155 | 0.0114 |
Echinococcus granulosus | mixed lineage leukemia protein mll | 0.0007 | 0.0155 | 0.0114 |
Schistosoma mansoni | cpg binding protein | 0.003 | 0.1344 | 0.1523 |
Echinococcus granulosus | geminin | 0.0177 | 0.8828 | 1 |
Brugia malayi | RNA binding protein | 0.0063 | 0.3029 | 0.2991 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0051 | 0.238 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0137 | 0.6769 | 0.6751 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.02 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0051 | 0.238 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0137 | 0.6769 | 0.7668 |
Schistosoma mansoni | hypothetical protein | 0.0063 | 0.302 | 0.3421 |
Schistosoma mansoni | bromodomain containing protein | 0.0005 | 0.0054 | 0.0062 |
Trichomonas vaginalis | cat eye syndrome critical region protein 2, cscr2, putative | 0.0043 | 0.1969 | 1 |
Schistosoma mansoni | bromodomain containing protein | 0.0005 | 0.0054 | 0.0062 |
Schistosoma mansoni | hypothetical protein | 0.0063 | 0.302 | 0.3421 |
Echinococcus multilocularis | Ataxin 2, N terminal,domain containing protein | 0.0023 | 0.0951 | 0.1022 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0094 | 0.4578 | 0.5186 |
Echinococcus granulosus | GPCR family 2 | 0.0063 | 0.302 | 0.338 |
Echinococcus granulosus | Ataxin 2 N terminaldomain containing protein | 0.0023 | 0.0951 | 0.1022 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0094 | 0.4578 | 0.5186 |
Echinococcus multilocularis | geminin | 0.0177 | 0.8828 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0063 | 0.3029 | 0.3431 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0094 | 0.4578 | 0.4548 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0141 | 0.6994 | 0.7911 |
Echinococcus multilocularis | tar DNA binding protein | 0.0063 | 0.3029 | 0.3391 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0063 | 0.3029 | 0.2991 |
Loa Loa (eye worm) | RNA binding protein | 0.0063 | 0.3029 | 0.2991 |
Echinococcus granulosus | tar DNA binding protein | 0.0063 | 0.3029 | 0.3391 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0051 | 0.238 | 1 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0061 | 0.291 | 0.3297 |
Schistosoma mansoni | hypothetical protein | 0.0023 | 0.0951 | 0.1077 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0051 | 0.238 | 0.5 |
Brugia malayi | F/Y-rich N-terminus family protein | 0.0009 | 0.0238 | 0.0185 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0137 | 0.6769 | 0.6751 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0094 | 0.4578 | 0.4548 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0094 | 0.4578 | 0.5156 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0244 | 0.0216 |
Brugia malayi | TAR-binding protein | 0.0063 | 0.3029 | 0.2991 |
Entamoeba histolytica | acetyltransferase, GNAT family | 0.0039 | 0.1787 | 0.5 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.0039 | 0.1787 | 0.5 |
Echinococcus multilocularis | cpg binding protein | 0.003 | 0.1344 | 0.147 |
Loa Loa (eye worm) | acetyltransferase | 0.0145 | 0.7202 | 0.7187 |
Loa Loa (eye worm) | hypothetical protein | 0.02 | 1 | 1 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0063 | 0.302 | 0.338 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0051 | 0.238 | 1 |
Brugia malayi | hypothetical protein | 0.0033 | 0.1462 | 0.1415 |
Brugia malayi | hypothetical protein | 0.0051 | 0.238 | 0.2338 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.